Jason Russell Chambers, Director at ARRHYTHMIA RESEARCH TECHNOLOGY INC /DE/ (HRT), bought 2,100 shares at $9.25 ($19K) on 2007-08-21, disclosed to the SEC on 2007-08-22.
Open-market purchase of $19k HRT by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| Filing → |
| HRT | SELL | 2015-06-16 | $8K | — | Filing → |
| HRT | SELL | 2014-08-14 | $37K | — | Filing → |
| HRT | BUY | 2008-09-16 | $32K | — | Filing → |